Detecting cancer gene mutations from home: What you need to know

By Allison MacAlister CCSN Communications & Social Media Coordinator On March 6th 2018, the DNA test company 23andMe announced that it now has approval to tell customers of their mail-in DNA-testing kit about three gene mutations of BRCA1 and BRCA2 as part of their genetic health results. What does that mean, and is it worth being concerned about? Let’s talk about the facts. Gene mutations?